Development and optimization of hydroxyapatite-ofloxacin implants for possible bone delivery in osteomyelitis treatment

Curr Drug Deliv. 2013 Apr;10(2):241-50. doi: 10.2174/1567201811310020008.

Abstract

The present study deals with preparation, optimization and in-vitro drug release study of hydroxyapatite (HAp)- ofloxacin for bone-implantable delivery in osteomyelitis treatment. The effect of drug amount added, and orthophosphoric acid addition rate as process parameters on the drug loading into HAp-system by precipitation method was optimized by using 32 factorial design. The response surface methodology utilizing polynomial equation was used to search for optimal drug loading into HAp-system. The responses observed coincided well with the predicted values obtained through optimization technique. HAp-ofloxacin bone-implants were manufactured using synthesized HAp-ofloxacin composite powders and 2 % w/v aqueous solution of sodium alginate was used as binder. Characterization of the delivery system was done by FTIR spectroscopy. The in-vitro ofloxacin release from optimized HAp-ofloxacin bone-implants was slow and sustained over 10 weeks. The drug release pattern was correlated well with Korsmeyer-Peppas model and was followed by Fickian (diffusional) release mechanism.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Bone and Bones / drug effects*
  • Drug Implants*
  • Durapatite / administration & dosage*
  • Humans
  • Ofloxacin / administration & dosage*
  • Ofloxacin / pharmacology
  • Ofloxacin / therapeutic use
  • Osteomyelitis / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Drug Implants
  • Durapatite
  • Ofloxacin